Hosted on MSN18d
Light-activated compound offers hope for overcoming drug resistance in cancer treatmentTo combat this autophagy, the research team designed a photoreactive compound that integrates morpholine and iridium. Morpholine selectively targets cell lysosomes, the organelles where autophagy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results